Document

CMS-2026-2180-0003

ICR 202611-0938-001 · OMB 0938-1078 · Object 174827300.

Document Viewer [pdf]

Status: Original and derived artifacts are available for this document.

Download: pdf

Primary: pdfSource: application/pdf
Loading document viewer…

Document Metadata

Record metadata
application/pdf
CMS-2026-2180-0003
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KH
2026-08-22
2026-08-22
complete

Extracted Text

8/22/26, 11:22 AM

CMS-2026-2180-0003.html

PUBLIC SUBMISSION

As of: 8/22/26, 11:22 AM
Received: August 10, 2026
Status: Posted
Posted: August 22, 2026
Tracking No. mso-2hzw-7xc3
Comments Due: August 10, 2026
Submission Type: Web

Docket: CMS-2026-2180
Collection Requirements for Compendia for Determination of Medically-accepted Indications for Offlabel Uses of Drugs and Biologicals in an Anti-cancer Chemotherapeutic Regimen (CMS-10302)
Comment On: CMS-2026-2180-0001
Collection Requirements for Compendia for Determination of Medically-accepted Indications for Offlabel Uses of Drugs and Biologicals in an Anti-cancer Chemotherapeutic Regimen (CMS-10302)
Document: CMS-2026-2180-0003
Comment on CMS-2026-2180-0001

Submitter Information
Name: Anonymous Anonymous

General Comment
CMS's estimate of 5.7 hours per response significantly undercounts the legal and administrative hours
required for compendia publishers to thoroughly audit, verify, and publicly disclose financial conflicts of
interest across multi-member oncology panels. Real-world panel auditing and verification require 15 to 25
hours per submission cycle.

file:///C:/Users/KU52/Downloads/CMS-2026-2180-0003.html

1/1